Title |
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, October 2018
|
DOI | 10.1186/s13063-018-2959-y |
Pubmed ID | |
Authors |
Dinesh Selvarajah, Jennifer Petrie, David White, Steven Julious, Oscar Bortolami, Cindy Cooper, Mike Bradburn, Amanda Loban, Helen Bowler, Lizzie Swaby, Katie Sutherland, Solomon Tesfaye |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 75% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 82 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 15% |
Student > Master | 8 | 10% |
Student > Ph. D. Student | 7 | 9% |
Student > Postgraduate | 5 | 6% |
Researcher | 5 | 6% |
Other | 8 | 10% |
Unknown | 37 | 45% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 20% |
Nursing and Health Professions | 8 | 10% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Psychology | 3 | 4% |
Other | 11 | 13% |
Unknown | 38 | 46% |